FDA panel backs Novartis’ pioneering new cancer gene therapy

July 13, 2017

The panel of cancer experts voted 10-0 Wednesday, recommending that the treatment be approved. Novartis plans further filings for CTL019 in the U.S. and EU later this year, including applications with the FDA and European Medicines Agency (EMA) for the treatment of adults with r/r diffuse large B-cell lymphoma (DLBCL). If positive, CTL019 would be the first CAR-T therapy in the market.


GOP Healthcare Plan Least Popular Bill in Three Decades

July 7, 2017

McConnell previously said that if there’s no agreement among Republicans, he will be forced to begin discussions with Minority Leader Charles E. Schumer, D-N.Y. Republican senators have been downplaying the chances of a quick vote on their ObamaCare replacement bill amid divisions in the party over what the legislation should look like.